In vitro inhibition of rat kidney plasma membrane Na-K-ATPase activity by triamterene.
In vitro experiments were performed to study the effect of 2,4,7-triamino-6-phenylpteridine (triamterene), a potassium sparing diuretic agent, upon the rat kidney plasma membrane Na-K-ATPase activity. Triamterene in the concentration range from 8X10(-13) mol/l to 8X10(-3) mol/l exerted a dose-dependent inhibitory effect of the rat kidney plasma membrane Na-K-Mg-ATPase and Na-K-ATPase activities--estimated IC50 values lay at about 8X10(-3) mol/l and 8X10(-7) mol/l, respectively. The diuretic did not influence the activity of Mg-ATPase, except at very high concentration. A Lineweaver-Burk analysis demonstrated that the inhibition of Na-K-ATPase by triamterene was non-competitive. The in vitro inhibitory effect, together with an in vivo effect observed before points to a possibility that the natriuresis caused by triamterene is due, at least partly, to a direct inhibition of active sodium transport across the kidney plasma membrane.
D000251:Adenosine Triphosphatases / Q000037:antagonists & inhibitors; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002462:Cell Membrane / Q000201:enzymology; D007668:Kidney / Q000201:enzymology*; D007700:Kinetics; D008297:Male; D051381:Rats; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*; D014223:Triamterene / Q000494:pharmacology*
D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D000254:Sodium-Potassium-Exchanging ATPase; D014223:Triamterene